Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®)
Go back to Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®)| (NASDAQ: ATRA) | Delayed: 9.49 +0.05 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.44 | 52 Week High | $40.80 | |||
| Open | $9.49 | 52 Week Low | $12.45 | |||
| Day High | $9.49 | P/E | N/A | |||
| Day Low | $9.49 | EPS | $0.00 | |||
| Volume | 743 | |||||

